- Q1 2024 Agios Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2024MXN397.93Earnings
- Q4 2023 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 15, 2024MXN397.93Earnings
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Agios Pharmaceuticals Inc ENERGIZE Phase 3 Topline Results TranscriptJan 03, 2024
- Q3 2023 Agios Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023MXN432.08Earnings
- Agios Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Agios Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2023MXN432.08Earnings
- Agios Pharmaceuticals Inc to Review the Rise up Phase 2 Data and next Steps for the Phase 3 Portion of the Study Call TranscriptJun 26, 2023
- Agios Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Q1 2023 Agios Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023MXN432.08Earnings
- Q4 2022 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 23, 2023MXN592.4Earnings
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Agios Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 Agios Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022MXN589.37Earnings
- Agios Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Agios Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022MXN506.43Earnings
- Agios Pharmaceuticals Inc Leadership Update TranscriptJul 12, 2022
- Agios Pharmaceuticals Inc Investor Event (Virtual) TranscriptJun 13, 2022
- Q1 2022 Agios Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022MXN651.66Earnings
- Q4 2021 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 24, 2022MXN607.61Earnings
- Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call TranscriptFeb 18, 2022
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2022
- Agios Pharmaceuticals Inc to Host Investor Webcast TranscriptDec 14, 2021
- Agios Pharmaceuticals Inc Investor Day TranscriptNov 17, 2021
- Q3 2021 Agios Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021MXN920Earnings
- Agios Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Agios Pharmaceuticals Inc Earnings Call TranscriptJul 29, 2021MXN1085Earnings
- Agios Pharmaceuticals Inc to Present Mitapivat Clinical Data at EHA Virtual Congress TranscriptJun 11, 2021
- Q1 2021 Agios Pharmaceuticals Inc Earnings Call TranscriptApr 29, 2021MXN1085Earnings
- Agios Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 17, 2021
- Agios Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021MXN1160Earnings
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Agios Pharmaceuticals Inc Investor Relations Event TranscriptDec 21, 2020
- Agios Pharmaceuticals Inc Virtual Investor Event to Review Data Presented at ASH TranscriptDec 08, 2020
- Agios Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 02, 2020
- Agios Pharmaceuticals Inc Webinar on Pyruvate Kinase-R (PKR) Activation Clinical Programs and Commercial Outlook TranscriptNov 19, 2020
- Q3 2020 Agios Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020MXN860 (-6.01%)Earnings
- Agios Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Agios Pharmaceuticals Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 13, 2020
- Q2 2020 Agios Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2020MXN1147Earnings
- Agios Pharmaceuticals Inc at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) TranscriptJun 23, 2020
- Agios Pharmaceuticals Inc Virtual Investor Webcast to Review Mitapivat Clinical Data Presented at EHA Annual Congress TranscriptJun 12, 2020
- Agios Pharmaceuticals Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Q1 2020 Agios Pharmaceuticals Inc Earnings Call TranscriptApr 30, 2020MXN1049.15Earnings
- Agios Pharmaceuticals Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Agios Pharmaceuticals Inc at Leerink Global Healthcare Conference TranscriptFeb 25, 2020
- Q4 2019 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 13, 2020MXN930.6Earnings
- Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Agios Pharmaceuticals Inc Investor Event to Review Data Presented at ASH TranscriptDec 10, 2019
- Q3 2019 Agios Pharmaceuticals Inc Earnings Call TranscriptOct 31, 2019MXN583Earnings
- Agios Pharmaceuticals Inc Investor Event to Review AG-270 Phase 1 Data and Research TranscriptOct 27, 2019
- Agios Pharmaceuticals Inc to Discuss Data from ClarIDHy Study Presented at ESMO - Conference Call TranscriptSep 30, 2019
- Agios Pharmaceuticals Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Agios Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2019Earnings
- Agios Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Q1 2019 Agios Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2019Earnings
- Agios Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 11, 2019
- Agios Pharmaceuticals Inc at Leerink Partners Global Healthcare Conference TranscriptFeb 28, 2019
- Q4 2018 Agios Pharmaceuticals Inc Earnings Call TranscriptFeb 14, 2019Earnings
Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call Transcript
All right. It's 7:00, so let's go ahead and get started. Thank you, everyone, for joining our approval event today. We will -- we have some prepared remarks. We'll go through our label and commercial plans. And then at the end, we'll have time for Q&A. (Operator Instructions) So Jackie, I will turn it over to you.
Thank you, Holly. Good early morning, everyone, and thank you for joining us early this morning. It's a very exciting time for us at Agios today as we got our first genetically defined disease indication drug approval yesterday, and we're just thrilled with that and look forward to speaking with you about it today.
Just as a reminder, less exciting, but necessary, this presentation will include forward-looking statements. Before we get started with the specifics of today's -- or yesterday, actually, announcement I want to start with one of the key ways that we differentiate ourselves at Agios with what
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)